ADM
30
-3
O
19
-12
AXP
69
2
EMC
71
3
AVB
57
-2
EL
34
-3
FCX
50
-2
DIS
72
-5
WFC
58
-2
EA
50
-2
GLW
42
-3
NWS
52
-4
VRSK
63
-3
IR
55
-3
TSN
28
-2
LYB
25
-14
FOX
68
-2
PSA
48
-2
NFLX
74
-2
PNC
53
-2
ADM
30
-3
O
19
-12
AXP
69
2
EMC
71
3
AVB
57
-2
EL
34
-3
FCX
50
-2
DIS
72
-5
WFC
58
-2
EA
50
-2
GLW
42
-3
NWS
52
-4
VRSK
63
-3
IR
55
-3
TSN
28
-2
LYB
25
-14
FOX
68
-2
PSA
48
-2
NFLX
74
-2
PNC
53
-2
Financhill
Back

Immunocore Holdings PLC 10K Form

Sell
37

IMCR
Immunocore Holdings PLC

Last Price:
28.90
Seasonality Move:
-9.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMCR News And Ratings

See the #1 stock for the next 7 days that we like better than IMCR

IMCR Financial Statistics

Sales & Book Value

Annual Sales: $249.43M
Cash Flow: $20.3M
Price / Cash Flow: 77.11
Annual Sales: $7.55
Price / Book: 4.01

Profitability

EPS (TTM): -0.95000
Net Income (TTM): $-47.05M
Gross Margin: $248.39M
Return on Equity: -12.92%
Return on Assets: -5.52%

Immunocore Holdings PLC Earnings Forecast

Key Immunocore Holdings PLC Financial Ratios

  • The Gross Profit Margin over the past 4 years for IMCR is 99.58%.
  • The Selling, General & Administrative Expenses for IMCR have been equal to 57.93% of Gross Profit Margin.
  • The Research & Development expenses have been 65.57% of Revenue.
  • The Interest Expense is -9.32% of Operating Income.
  • The Net Earning history of IMCR is -22.17% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Immunocore Holdings PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMCR
Website: immunocore.com

Debt

Debt-to-Equity Ratio: 1.16
Current Ratio: 3.78
Quick Ratio: 3.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMCR Technical Analysis vs Fundamental Analysis

Sell
37
Immunocore Holdings PLC (IMCR) is a Sell

Is Immunocore Holdings PLC a Buy or a Sell?